Boston Scientific
-
Boston Scientific (BSX) Q4 Earnings on Deck: What Analysts Expect
Medical device giant Boston Scientific (NYSE:BSX) is poised to release its fourth-quarter earnings report on Wednesday, February 4, 2026, with analysts forecasting robust revenue growth and strong per-share earnings, continuing a trend of exceeding market expectations.
-
Boston Scientific Acquires Penumbra for $14.5 Billion, Reshaping Vascular Medtech
Boston Scientific has announced its acquisition of Penumbra, a leader in vascular technologies, for an estimated $14.5 billion. This landmark deal is set to expand Boston Scientific’s presence in fast-growing segments like mechanical thrombectomy, promising to redefine patient care for…


